We therefore investigated whether modulating the levels of nuclear NMNAT1 alters the progression of early behavioral dysfunctions and pathological abnormalities, in the htau mouse model of tauopathy which has particular relevance to AD [21] by crossing htau mice with Nmnat1 transgenic and knockout mice [22], [23]. The gene discussed is NMNAT1; the disease is Alzheimer disease.